153 related articles for article (PubMed ID: 31788994)
21. Prevalence of high risk human papillomavirus (HPV) infection and abnormal cervical cytology and knowledge about HPV vaccine in Eastern Turkey.
Sahin HG; Kolusari A; Guducuoglu H
Eur J Gynaecol Oncol; 2017; 38(2):241-244. PubMed ID: 29953788
[TBL] [Abstract][Full Text] [Related]
22. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
Učakar V; Poljak M; Oštrbenk A; Klavs I
J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
[TBL] [Abstract][Full Text] [Related]
23. Human Papillomavirus Genotype Distribution Among 18,815 Women in 13 Korean Cities and Relationship With Cervical Cytology Findings.
Nah EH; Cho S; Kim S; Cho HI
Ann Lab Med; 2017 Sep; 37(5):426-433. PubMed ID: 28643492
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings.
Tezcan S; Ozgur D; Ulger M; Aslan G; Gurses I; Serin MS; Giray BG; Dilek S; Emekdas G
Asian Pac J Cancer Prev; 2014; 15(9):3997-4003. PubMed ID: 24935586
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
26. Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study.
Tabrizi SN; Brotherton JM; Kaldor JM; Skinner SR; Liu B; Bateson D; McNamee K; Garefalakis M; Phillips S; Cummins E; Malloy M; Garland SM
Lancet Infect Dis; 2014 Oct; 14(10):958-66. PubMed ID: 25107680
[TBL] [Abstract][Full Text] [Related]
27. Effect of human papillomavirus vaccination on cervical cancer screening in Alberta.
Kim J; Bell C; Sun M; Kliewer G; Xu L; McInerney M; Svenson LW; Yang H
CMAJ; 2016 Sep; 188(12):E281-E288. PubMed ID: 27378467
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of high risk human papillomavirus infection with different cervical cytological features among women undergoing health examination at the National Cancer Institute, Thailand.
Laowahutanont P; Karalak A; Wongsena M; Loonprom K; Pukcharoen P; Jamsri P; Sangrajrang S
Asian Pac J Cancer Prev; 2014; 15(14):5879-82. PubMed ID: 25081717
[TBL] [Abstract][Full Text] [Related]
29. HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program.
Tabrizi SN; Brotherton JM; Stevens MP; Condon JR; McIntyre P; Smith D; Garland SM;
J Clin Virol; 2014 Jul; 60(3):250-6. PubMed ID: 24854516
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of Human Papillomavirus Vaccination on Prevalence of Vaccine Genotypes in Young Sexually Active Women in France.
Heard I; Tondeur L; Arowas L; Demazoin M; Falguières M; Parent Du Chatelet I;
J Infect Dis; 2017 Mar; 215(5):757-763. PubMed ID: 28011911
[TBL] [Abstract][Full Text] [Related]
31. Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.
Goggin P; Sauvageau C; Gilca V; Defay F; Lambert G; Mathieu-C S; Guenoun J; Comète E; Coutlée F
Hum Vaccin Immunother; 2018 Jan; 14(1):118-123. PubMed ID: 29049007
[TBL] [Abstract][Full Text] [Related]
32. Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions.
Powell SE; Hariri S; Steinau M; Bauer HM; Bennett NM; Bloch KC; Niccolai LM; Schafer S; Unger ER; Markowitz LE
Vaccine; 2012 Dec; 31(1):109-13. PubMed ID: 23137842
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of Vaccine Type Infections in Vaccinated and Non-Vaccinated Young Women: HPV-IMPACT, a Self-Sampling Study.
Jeannot E; Viviano M; de Pree C; Amadane M; Kabengele E; Vassilakos P; Petignat P
Int J Environ Res Public Health; 2018 Jul; 15(7):. PubMed ID: 29987255
[TBL] [Abstract][Full Text] [Related]
34. Analysis of Human Papillomavirus Infection in 16,320 Patients From a Gynecology Clinic in Central South China.
Xiao SS; Fan JL; He SL; Li YR; Wang LY; Yu KN; Deng XL; Xue M
J Low Genit Tract Dis; 2016 Oct; 20(4):327-31. PubMed ID: 27482797
[TBL] [Abstract][Full Text] [Related]
35. Non-Vaccine-Type Human Papillomavirus Prevalence After Vaccine Introduction: No Evidence for Type Replacement but Evidence for Cross-Protection.
Saccucci M; Franco EL; Ding L; Bernstein DI; Brown D; Kahn JA
Sex Transm Dis; 2018 Apr; 45(4):260-265. PubMed ID: 29465705
[TBL] [Abstract][Full Text] [Related]
36. Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program.
Garland SM; Cornall AM; Brotherton JML; Wark JD; Malloy MJ; Tabrizi SN;
Vaccine; 2018 May; 36(23):3221-3230. PubMed ID: 29724506
[TBL] [Abstract][Full Text] [Related]
37. Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy.
Carozzi F; Puliti D; Ocello C; Anastasio PS; Moliterni EA; Perinetti E; Serradell L; Burroni E; Confortini M; Mantellini P; Zappa M; Dominiak-Felden G
BMC Infect Dis; 2018 Jan; 18(1):38. PubMed ID: 29334901
[TBL] [Abstract][Full Text] [Related]
38. Preventive effect of human papillomavirus vaccination on the development of uterine cervical lesions in young Japanese women.
Tanaka H; Shirasawa H; Shimizu D; Sato N; Ooyama N; Takahashi O; Terada Y
J Obstet Gynaecol Res; 2017 Oct; 43(10):1597-1601. PubMed ID: 28707725
[TBL] [Abstract][Full Text] [Related]
39. Enhanced disease progression due to persistent HPV-16/58 infections in Korean women: a systematic review and the Korea HPV cohort study.
Seong J; Ryou S; Lee J; Yoo M; Hur S; Choi BS;
Virol J; 2021 Sep; 18(1):188. PubMed ID: 34535177
[TBL] [Abstract][Full Text] [Related]
40. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
